Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding (GI) in hospitalized patients has increased significantly, with some studies estimating that as ...
Feb 14, 2011
4 / 5 (1)
0
Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epi ...
Nov 24, 2010
not rated yet
0
Using proton pump inhibitors (PPIs) and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular (CV) disease who are at high risk of upper gastrointestinal (GI) bleeds, ...
Nov 08, 2010
5 / 5 (1)
0
In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium di ...
Oct 18, 2010
not rated yet
0
(PhysOrg.com) -- In a study that could revolutionize how millions of people are treated for painful gastric acid-related diseases, a team led by Yale School of Medicine researchers has shown that zinc salts offer rapid, prolonged ...
Aug 24, 2010
4.3 / 5 (6)
0
| 
(PhysOrg.com) -- If you constantly pop pills and still suffer from irritating heartburn, there may be an underlying problem more effectively -- and safely -- addressed with surgery.
Jul 16, 2010
4 / 5 (2)
2
Proton pump inhibitors, medications that suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial ...
May 10, 2010
5 / 5 (1)
0
Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases. Physicians are warned to monitor these ...
Nov 03, 2009
not rated yet
0
Gastroesophageal reflux disease (GERD) is the most common esophageal disorder, and frequently encountered in the primary care setting. Accumulating evidence has confirmed the excellent efficacy and safety of proton pump inhibitor ...
Oct 23, 2009
5 / 5 (1)
1
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines ...
Sep 24, 2009
not rated yet
0
Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use.
Sep 09, 2009
5 / 5 (2)
0
Treatment with proton pump inhibitors (PPIs) for eight weeks induces acid-related symptoms like heartburn, acid regurgitation and dyspepsia once treatment is withdrawn in healthy individuals, according to a new study in Gastroenterology, th ...
Jul 01, 2009
5 / 5 (1)
0
The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for ...
May 06, 2009
not rated yet
0
A commonly used treatment for acid reflux does not improve asthma symptoms or control in patients who do not have symptoms of gastroesophageal reflux (GER), according to a new study supported by the National Heart, Lung, ...
Apr 08, 2009
not rated yet
0
Patients taking the common cardiac drug clopidogrel following a heart attack are at a significantly higher risk of a recurrence if they are also taking widely used acid-lowering medications called proton pump inhibitors, ...
Jan 28, 2009
not rated yet
0
